eperezolid,
N-((3-(3-fluoro-4-(N-1-(4-hydroxyacetyl)piperazinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide,
U 100592,
U-100592,
Eperezolid,
165800-04-4,
U-100592,
UNII-C460ZSU1OW,
PNU 100592,
C18H23FN4O5,
C460ZSU1OW,
U 100592,
Acetamide, N-((3-(3-fluoro-4-(4-(hydroxyacetyl)-1-piperazynyl)phenyl)- 2-oxo-5-oxazolidinyl)methyl)-, (S)-,
N-(((S)-3-(3-fluoro-4-(4-glycoloyl-1-piperazinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide,
Acetamide, N-((3-(3-fluoro-4-(4-(hydroxyacetyl)-1-piperazinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (S)-,
Eperezolid [USAN],
Eperezolid [USAN:INN],
AC1L2JGQ,
AC1Q5LET,
Eperezolid (USAN/INN),
CHEMBL47955,
SCHEMBL186562,
DTXSID50168028,
SIMWTRCFFSTNMG-AWEZNQCLSA-N,
ZINC3813328,
3614AH,
BDBM50433368,
AKOS015951014,
CS-2793,
LS-9620,
NCGC00378601-01,
acetamide, n-[[(5s)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-,
AJ-45696,
HY-10393,
AB1006800,
D04017,
U-100,592,
(S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1 -piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide,
(S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide,
(S)-N-[[3-[3-fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide,
Acetamide, N-((3-(3-fluoro-4-(4-(hydroxyacetyl)-1-piperazynyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (S)-,
N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-Acetamide,
N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)piperazin-1-yl]phenyl]-2-oxo-oxazolidin-5-yl]methyl]acetamide,
D0YE2N,
CID73214,
AR-1H6265,
C18-H23-F-N4-O5,
PNU-100592,
A13486,
(S)-N-((3-(3-fluoro-4-thiomorpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide,
16905-14-9,
N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide,